Evidence map›Paper›PMID 21996343›Full record

ArticleThe Journal of allergy and clinical immunology2011

Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps.

Bruce K Tan, Quan-Zhen Li, Lydia Suh, Atsushi Kato, David B Conley, Rakesh K Chandra, Jinchun Zhou, James Norton, Roderick Carter, Monique Hinchcliff and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 9 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 9 syntheses or guidelines pooled it, 186 citations in OpenAlex.

  1. Biologics for chronic rhinosinusitis.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Biologics for chronic rhinosinusitis.The Cochrane database of systematic reviews · 2020
    Pooled it
  3. Topical and systemic antifungal therapy for chronic rhinosinusitis.The Cochrane database of systematic reviews · 2018
    Pooled it
  4. Systemic and topical antibiotics for chronic rhinosinusitis.The Cochrane database of systematic reviews · 2016
    Pooled it
  5. Pooled it
  6. Saline irrigation for chronic rhinosinusitis.The Cochrane database of systematic reviews · 2016
    Pooled it
  7. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis.The Cochrane database of systematic reviews · 2016
    Pooled it
  8. Different types of intranasal steroids for chronic rhinosinusitis.The Cochrane database of systematic reviews · 2016
    Pooled it
  9. Short-course oral steroids alone for chronic rhinosinusitis.The Cochrane database of systematic reviews · 2016
    Pooled it
  10. P-glycoprotein expression in sinonasal inverted papillomas and polyps: Marker or bystander?European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  11. Autoallergy in chronic rhinosinusitis and its clinical relevance.The World Allergy Organization journal · 2026
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. New insights into the mechanisms of aspirin-exacerbated respiratory disease.Current opinion in allergy and clinical immunology · 2025
    Review
  17. Anti-IgE therapy in chronic rhinosinusitis with nasal polyps.The Journal of allergy and clinical immunology · 2025
    Review
  18. Article
  19. Eosinophil extracellular traps in respiratory ailment: Pathogenic mechanisms and clinical translation.World journal of otorhinolaryngology - head and neck surgery · 2024
    Review
  20. CXCR5Frontiers in immunology · 2024
    Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Bruce K TanDepartment of Otolaryngology-Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. btan@nmff.org
Quan-Zhen Li
Lydia Suh
Atsushi Kato
David B Conley
Rakesh K Chandra
Jinchun Zhou
James Norton
Roderick Carter
Monique Hinchcliff
Kathleen Harris
Anju Peters
Leslie C Grammer
Robert C Kern
Chandra Mohan
Robert P Schleimer
Northwestern University · USBipar · FRThe University of Texas Southwestern Medical Center · US

Funding

Glucocorticosteroid Action In Inflammatory DiseaseR37HL068546 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHLEIMER, ROBERT P · 2009 to 2018
$3.5M
Role of Epithelium in Immunity, Inflammation and DiseaseR01HL078860 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHLEIMER, ROBERT P · 2006 to 2013
$3.0M
GLUCOCORTICOSTEROID ACTION IN INFLAMMATORY DISEASER01HL068546 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHLEIMER, ROBERT P · 2001 to 2008
$2.9M
Epithelial BAFF and APRIL in Airway Inflammation, Immunity and DiseaseR01AI072570 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHLEIMER, ROBERT P · 2007 to 2011
$2.3M
Role for B-cell mediated olfactory loss in Chronic Sinusitis with Nasal PolypsK23DC012067 · NIDCD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI TAN, BRUCE K · 2012 to 2016
$1.1M
NHLBI NIH HHS R01 HL068546NHLBI NIH HHS R01 HL078860NHLBI NIH HHS R37 HL068546NIAID NIH HHS R01 AI072570NIDCD NIH HHS K23 DC012067
6 · The paper itself

Abstract

backgroundChronic rhinosinusitis (CRS) with nasal polyps is an inflammatory condition of the nasal passage and paranasal sinuses characterized by T(H)2-biased inflammation with increased levels of B-cell activating factor of the TNF family (BAFF), B lymphocytes, and immunoglobulins. Because high levels of BAFF are associated with autoimmune diseases, we assessed for evidence of autoimmunity in patients with CRS.

objectivesThe objective of this study was to investigate the presence of autoantibodies in sinonasal tissue from patients with CRS.

methodsStandardized nasal tissue specimens were collected from patients with CRS and control subjects and assayed for immunoglobulin production, autoantibody levels, tissue distribution of immunoglobulins, and binding potential of antibodies in nasal tissue with a multiplexed autoantibody microarray, ELISA, and immunofluorescence.

resultsIncreased levels of several specific autoantibodies were found in nasal polyp tissue in comparison with levels seen in control tissue and inflamed tissue from patients with CRS without nasal polyps (P < .05). In particular, nuclear-targeted autoantibodies, such as anti-dsDNA IgG and IgA antibodies, were found at increased levels in nasal polyps (P < .05) and particularly in nasal polyps from patients requiring revision surgery for recurrence. Direct immunofluorescence staining demonstrated diffuse epithelial and subepithelial deposition of IgG and increased numbers of IgA-secreting plasma cells not seen in control nasal tissue.

conclusionsAutoantibodies, particularly those against nuclear antigens, are present at locally increased levels in nasal polyps. The presence of autoantibodies suggests that the microenvironment of a nasal polyp promotes the expansion of self-reactive B-cell clones. Although the pathogenicity of these antibodies remains to be elucidated, the presence of increased anti-dsDNA antibody levels is associated with a clinically more aggressive form of CRS with nasal polyps requiring repeated surgery.

Indexed as

AdultAntibodies, AntinuclearChronic DiseaseEnzyme-Linked Immunosorbent AssayFemaleFluorescent Antibody TechniqueHumansImmunoglobulin AImmunoglobulin GMaleMiddle AgedNasal MucosaNasal PolypsProtein Array AnalysisRhinitisSinusitisAntibodies, AntinuclearImmunoglobulin AImmunoglobulin G

Identifiers

PMID21996343
PMCPMC3384688
OpenAlexW2010668367

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.